We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+10.76%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$138B
AUM Growth
+$19.4B
Cap. Flow
+$7.6B
Cap. Flow %
5.51%
Top 10 Hldgs %
15.42%
Holding
4,486
New
399
Increased
2,092
Reduced
1,353
Closed
351

Sector Composition

Rank Sector Weight
1 Healthcare 12.22%
2 Technology 11.9%
3 Financials 9.98%
4 Consumer Discretionary 7.32%
5 Communication Services 5.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TWOU
1076
DELISTED
2U Inc
TWOU
$18.2M 0.01%
25,308
+15,242
+151% +$9.48M
AAL icon
1077
American Airlines Group
AAL
$10.1B
$18.2M 0.01%
634,458
+115,912
+22% +$3.31M
ABT icon
1078
CALL
Abbott
ABT
$183B
$18.2M 0.01%
209,500
+123,600
+144% +$10.4M
XBI icon
1079
State Street SPDR S&P Biotech ETF
XBI
$9.95B
$18.1M 0.01%
190,468
-734,528
-79% -$63.5M
SNP
1080
DELISTED
CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES)
SNP
$18.1M 0.01%
300,756
-93,598
-24% -$5.43M
ET icon
1081
CALL
Energy Transfer Partners
ET
$70.1B
$18.1M 0.01%
1,410,000
+1,370,200
+3,443% +$16.9M
LAZ icon
1082
Lazard
LAZ
$4.13B
$18.1M 0.01%
451,749
+292,977
+185% +$11.1M
CPRI icon
1083
Capri Holdings
CPRI
$1.83B
$18M 0.01%
472,338
+138,168
+41% +$4.77M
NSC icon
1084
CALL
Norfolk Southern
NSC
$75.4B
$18M 0.01%
92,600
+62,600
+209% +$11.7M
FBIN icon
1085
Fortune Brands Innovations
FBIN
$5.88B
$18M 0.01%
321,718
+124,319
+63% +$6.54M
HAE icon
1086
Haemonetics
HAE
$3.89B
$18M 0.01%
156,274
+100,695
+181% +$12.2M
LOPE icon
1087
Grand Canyon Education
LOPE
$3.79B
$17.9M 0.01%
187,132
+159,622
+580% +$14.7M
CMI icon
1088
PUT
Cummins
CMI
$87.5B
$17.9M 0.01%
+100,000
New +$17.6M
LYFT icon
1089
Lyft
LYFT
$6.02B
$17.9M 0.01%
415,887
-264,879
-39% -$11.6M
ACC
1090
DELISTED
American Campus Communities, Inc.
ACC
$17.9M 0.01%
380,253
+53,258
+16% +$2.55M
CVS icon
1091
CALL
CVS Health
CVS
$133B
$17.9M 0.01%
240,600
+140,600
+141% +$9.87M
BURL icon
1092
Burlington
BURL
$23.2B
$17.9M 0.01%
78,312
-15,500
-17% -$3.24M
WUBA
1093
DELISTED
58.com Inc
WUBA
$17.8M 0.01%
275,660
+45,605
+20% +$2.57M
NOV icon
1094
NOV
NOV
$6.93B
$17.8M 0.01%
712,161
+33,939
+5% +$764K
ONC
1095
BeOne Medicines Ltd
ONC
$32.8B
$17.8M 0.01%
107,148
+21,517
+25% +$3.57M
WTRG icon
1096
Essential Utilities
WTRG
$11.3B
$17.7M 0.01%
377,233
+90,333
+31% +$4.07M
BLK icon
1097
CALL
Blackrock
BLK
$169B
$17.7M 0.01%
35,200
-100,000
-74% -$47.4M
REGN icon
1098
CALL
Regeneron Pharmaceuticals
REGN
$78.5B
$17.7M 0.01%
47,100
TDY icon
1099
Teledyne Technologies
TDY
$30.4B
$17.7M 0.01%
50,956
-3,311
-6% -$1.11M
SIRI icon
1100
SiriusXM
SIRI
$9.98B
$17.6M 0.01%
246,087
-34,124
-12% -$2.3M

Similar funds

Credit Suisse's Q4 2019 Portfolio in Review

As of Q4 2019, Credit Suisse held 4,486 positions worth $138B, up 16% from $119B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Credit Suisse deployed $7.6B of net new capital in Q4 2019, opening 399 new positions and adding to 2,092 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 1,727,952 shares worth $76M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 12% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Vanguard Extended Market ETF, an estimated $566M trimmed.

  • Credit Suisse's largest Q4 2019 buy was iShares Russell 1000 Growth ETF: 1,727,952 shares worth $76M.
  • Credit Suisse added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $1.28B increase.
  • Credit Suisse's biggest Q4 2019 reduction was Vanguard Extended Market ETF, cutting an estimated $566M.
  • Credit Suisse fully exited Celgene Corp in Q4 2019, selling an estimated $685M.
  • Credit Suisse's ten largest holdings make up 15% of its $138B portfolio in Q4 2019.
  • Credit Suisse opened 399 new positions and closed 351 in Q4 2019.
  • Credit Suisse's portfolio value rose 16% quarter-over-quarter to $138B.

Based on Credit Suisse's 13F filing for Q4 2019, filed 12 Feb 2020.